NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
NT 201, also known as IncobotulinumtoxinA (Xeomin®/Bocouture®), is a Botulinum toxin type A
preparation free of complexing proteins (150 kiloDalton). Injected into the muscle, NT201
causes a reversible local relaxation of the injected muscle. Botulinum toxin type A is used
for aesthetic treatment of mimic wrinkles and in the therapy of neurologic diseases. This
study will investigate the safety and efficacy (non-inferiority) of NT 201 in comparison with
OnabotulinumtoxinA (Vistabel®) in the treatment of glabellar frown lines.
Phase:
Phase 3
Details
Lead Sponsor:
Merz Pharmaceuticals GmbH
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA